AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
48.38
+0.41 (0.85%)
Nov 10, 2026, 4:00 PM EST - Market closed
AnaptysBio Market Cap
AnaptysBio has a market cap or net worth of $1.45 billion as of November 10, 2026. It is the 8,121st most valuable company in the world and the 1,995th biggest in the United States. Its market cap has increased by 31.75% in one year.
Market Cap
1.45B
Enterprise Value
1.55B
1-Year Change
31.75%
Global Rank
Country Rank
#1,995 United States
Category
ChartMarket Cap Chart
Since January 26, 2017, AnaptysBio's market cap has increased from $308.70M to $1.45B, an increase of 368.52%. That is a compound annual growth rate of 17.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 1.45B | 7.75% |
| Dec 31, 2025 | 1.34B | 233.16% |
| Dec 31, 2024 | 402.90M | -29.22% |
| Dec 29, 2023 | 569.20M | -35.40% |
| Dec 30, 2022 | 881.10M | -7.83% |
| Dec 31, 2021 | 955.90M | 62.57% |
| Dec 31, 2020 | 588.00M | 33.36% |
| Dec 31, 2019 | 440.90M | -74.16% |
| Dec 31, 2018 | 1.71B | -27.90% |
| Dec 29, 2017 | 2.37B | 666.67% |
| Jan 26, 2017 | 308.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tyra Biosciences | 1.45B |
| Kardigan | 1.45B |
| Structure Therapeutics | 1.45B |
| Rapport Therapeutics | 1.45B |
| Ocular Therapeutix | 1.45B |
| Korsana Biosciences | 1.41B |
| Taysha Gene Therapies | 1.41B |
| Ascentage Pharma Group International | 1.37B |